PI11303 3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone (CAS No.: 120004-79-7)

3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone (CAS No.: 120004-79-7) Description

This compound, with a molecular formula C13H16ClNO2, is employed as an active intermediate in pharmaceutical development. Its well-characterised structure ensures predictable reactivity and ease of integration within synthetic protocols. The powder form aids in precise weighing and dispensing, facilitating both laboratory-scale reactions and industrial processes. Quality assessments guarantee controlled impurity profiles, supporting effective synthesis of final therapeutic agents.

3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone (CAS No.: 120004-79-7) Applications

1.         Pharmaceutical Synthesis
   - Used as a synthetic intermediate in drug production to achieve defined reaction pathways by leveraging its predictable reactivity.
   - Applied as a reagent in active pharmaceutical ingredient (API) manufacturing to optimise yield by maintaining controlled impurity profiles.

2.         Chemical Research and Development
   - Employed as a model compound in organic synthesis studies to verify reaction mechanisms by leveraging its well-characterised molecular structure.
   - Used in R&D laboratories for process optimisation, providing consistent performance in reaction trials due to its uniform chemical properties.

3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone (CAS No.: 120004-79-7) Packing

The compound is packaged in sealed, moisture-resistant containers with an inert gas blanket to prevent oxidation and contamination. Anti-static measures and tamper-evident seals are integrated into the packaging design. It is recommended to store the product in a cool, dry place to preserve its chemical stability. Custom packaging options are available for bulk shipments and specialised storage requirements.

Additional Information

Pharmaceutical intermediates like 3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone play a crucial role in the synthesis of complex therapeutic agents. Their precise molecular structures allow chemists to predict reaction mechanisms and tailor synthesis protocols to achieve specific biological activities. Advances in analytical techniques provide detailed impurity profiles, which are essential for maintaining consistency across production batches.

In the broader context of organic synthesis and materials science, understanding the properties of intermediates is essential for improving reaction efficiency and product quality. Enhancements in quality control and analytical methods facilitate the translation of laboratory-scale findings to industrial manufacturing, ensuring that compounds perform as expected in final applications.